While the overall incidence was lower than previously reported rates of 30%50% ( The mechanisms underlying GLP-1RA-induced gastrointestinal adverse events are not yet fully understood
Microchim Acta 173(12):241247 Dale Y, Mackey V, Mushi R, Nyanda A, Maleque M, Ike J (2003) Simultaneous measurement of phenylalanine and tyrosine in phenylketonuric plasma and dried blood by high-performance liquid chromatography
Report of two cases - PubMed [Internet]
15 By incorporating glucagon receptor activation into GLP-1/GIP-based therapies, researchers aim to counteract metabolic adaptation that limits weight loss over time
This is where MeAgain's GLP-1 app fits in, addressing dosing consistency, symptom logging, and protein and hydration tracking so clinicians get time-stamped data to guide titration and troubleshooting